Bisphosphonates target multiple sites in both cis- and trans- prenyltransferases

Rey Ting Guo, Rong Cao, Po Huang Liang, Tzu Ping Ko, Tao Hsin Chang, Michael P. Hudock, Wen Yih Jeng, Cammy K.M. Chen, Yonghui Zhang, Yongcheng Song, Chih Jung Kuo, Fenglin Yin, Eric Oldfield, Andrew H.J. Wang

研究成果: Article同行評審

154 引文 斯高帕斯(Scopus)

摘要

Bisphosphonate drugs (e.g., Fosamax and Zometa) are thought to act primarily by inhibiting farnesyl diphosphate synthase (FPPS), resulting in decreased prenylation of small GTPases. Here, we show that some bisphosphonates can also inhibit geranylgeranyl diphosphate synthase (GGPPS), as well as undecaprenyl diphosphate synthase (UPPS), a cis-prenyltransferase of interest as a target for antibacterial therapy. Our results on GGPPS (10 structures) show that there are three bisphosphonate-binding sites, consisting of FPP or isopentenyl diphosphate substrate-binding sites together with a GGPP product- or inhibitor-binding site. In UPPS, there are a total of four binding sites (in five structures). These results are of general interest because they provide the first structures of GGPPS-and UPPS-inhibitor complexes, potentially important drug targets, in addition to revealing a remarkably broad spectrum of binding modes not seen in FPPS inhibition.

原文English
頁(從 - 到)10022-10027
頁數6
期刊Proceedings of the National Academy of Sciences of the United States of America
104
發行號24
DOIs
出版狀態Published - 2007 6月 12

All Science Journal Classification (ASJC) codes

  • 多學科

指紋

深入研究「Bisphosphonates target multiple sites in both cis- and trans- prenyltransferases」主題。共同形成了獨特的指紋。

引用此